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SIFAT ANTIBAKTERIA DAN PENYEMBUHAN LUKA IN VITRO OLEH 
FRAKSI KAYA POLIFENOL TERPIAWAI DICRANOPTERIS LINEARIS 
(BURM.) UNDERWOOD 
 
ABSTRAK 
 
Dicranopteris linearis (Burm.) Underwood merupakan sejenis paku-pakis 
menjalar tanah yang digunakan secara tradisional untuk merawat pelbagai penyakit 
kulit seperti bisul, ulser dan luka luaran. Sehingga kini, tiada kajian saintifik yang 
dijalankan secara sistematik untuk menilai kegunaan etnofarmakologikal D. linearis 
untuk mempercepatkan penyembuhan luka.Dalam kajian ini, ekstrak MeOH daripada 
D. linearis telah diperkaya dengan sebatian bioaktif dengan menggunakan kaedah 
berpandukan bioaktiviti. Salah satu fraksi ekstrak (F5) yang diperoleh telah didapati 
memiliki aktiviti antioksidan dan aktiviti antibakteria yang signifikan terhadap S. 
aureus dan P. aeruginosa. Analisis telah dilanjutkan untuk mengenal pasti kompoun 
dalam fraksi aktif ini. Pemencilan sebatian telah dijalankan dengan menggunakan 
gabungan teknik kromatokrafi.gel silica fasa terbalik dan normal. Dua sebatian 
fenolik yang penting secara taksonomi D. linearis, iaitu dikotomain A (2) dan 
dikotomain B(3), dua sebatian baru, 4-vinil fenol-1-O- (2'-O-α-ramnopiranosil) -β- 
glukopiranosida(5) dan 4-vinil fenol-1-O- (4'-O-α-ramnopiranosil)-β-
glukopiranosida(6) bersama-sama dua lagi flavonoid yang telah dilaporkan sebelum 
ini, kaempferol 3-O- β-glukopiranosida(1) dan kaempferol 3-O -β-glukosil (1 → 2) -
β-glukosida(4) telah dikenalpasti. Pencirian kompoun-kompoun tersebut telah 
xxvi 
 
dijalankan dengan menggunakan pelbagai teknik spektroskopi seperti UV, IR, NMR 
dan MS. Untuk menentukan kandungan F5 dan pemiawaian fraksi induknya, satu 
kaedah HPLC-DAD yang baru telah dibangunkan dan disahsahihkan menggunakan 
sebatian yang telah dipencilkan sebagai penanda analisis. Kaedah ini didapati jitu 
dan persis dengan LOQ 1.56 µg/mL untuk sebatian 1, 4, 5 & 6 dan 15.6 µg/mL 
untuk kompoun 2. Kandungan sebatian telah didapati sebanyak 3.1% untuk sebatian 
1, 3.4% untuk  sebatian 2, 3.4% untuk sebatian 4, dan 26.8% untuk sebatian 5 & 
6.Aktiviti antibakteria dan potensi penyembuhan luka fraksi terpiawai F5 D. linearis 
telah dikaji seterusnya dengan menggunakan beberapa cerakin in vitro. Daripada 
cerakin masa-membunuh bakteria, cerakin kepekatan minimum perencatan bakteria 
(MBC) dan imej mikroskopik elektron pengimbasan, fraksi F5 didapati memberi 
kesan bacteriostatik terhadap S. aureus dan P. aeruginosa. Tambahan pula, F5 dapat 
meningkatkan potensi aktiviti antibakteria beberapa antibiotik konvensional, iaitu, 
kloramfenikol, penisilin G dan ampisilin terhadap S. aureus dan MRSA. Sebaliknya, 
F5 didapati meningkatkan proliferasi sel-sel fibroblast dan mengaruh penghijrahan 
sel dalam cerakin calar luka. Tambahan pula, ia juga memberi kesan perlindungan 
sel-sel daripada tekanan oksidatif yang disebabkan oleh hidrogen peroksida dan tidak 
mengakibatkan kesan sitotoksik-ke arah kedua-dua sel fibroblast manusia dan tikus 
pada kepekatan yang diuji, 500μg/mL. Kesimpulannya, kajian ini memberikan 
maklumat baru untuk menyokong penggunaan tradisional tumbuhan ini untuk 
mengubati jangkitan kulit. Kajian in vivo perlu dijalankan untuk meneroka 
perkembangan potensi D. linearis sebagai agen penyembuhan luka. 
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IN VITRO ANTIBACTERIAL AND WOUND HEALING PROPERTIES OF A 
STANDARDIZED POLYPHENOLS-RICH FRACTION OF 
DICRANOPTERIS LINEARIS (BURM.) UNDERWOOD 
 
ABSTRACT 
 
Dicranopteris linearis (Burm.)Underwood is a ground creeping fern used 
traditionally to treat various skin related ailments, such as boils, ulcers and external 
wounds. To date, no scientific studies have been carried out to evaluate its 
ethnopharmacological use in wound infection in a systematic manner. In the present 
study, the MeOH extract of D. linearis was fractionated with the bioactive 
constituents following a bioactivity-guided approach. A fraction (F5) of the extract 
was obtained and it was found to possess significant antioxidant and antibacterial 
activity against S. aureus and P. aeruginosa. Analysis was further carried out to 
identify the chemical constituents of this active fraction. Isolation of the major 
constituents was carried out using a combination of reversed-phase and normal-phase 
silica gel chromatographic techniques. Two phenolic compounds which are 
taxonomically significant to D. linearis, namely dichotomain A (2) and dichotomain 
B (3), and two new compounds, 4-vinyl phenol-1-O-(2‟-O-α-L-rhamnopyranosyl)-β-
D-glucopyranoside (5) and 4-vinyl phenol-1-O-(4‟-O-α-L-rhamnopyranosyl)-β-D-
glucopyranoside (6) together with two other known compounds kaempferol 3-O-β-
D-glucopyranoside (1) and kaempferol 3-O-β-D-glucosyl (1→2)-β-glucoside (4) 
were obtained. Characterization of the constituents was carried out using various 
spectroscopic techniques such as UV, IR, NMR and MS. In order to determine the 
content of F5 and to standardize the fraction, a novel HPLC–DAD method was 
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developed and validated using the isolated compounds as analytical markers. This 
method was found to be accurate and precise, with an LOQ of 1.56 µg/mL for 
compounds 1, 4, 5& 6 and 15.6 µg/mL for compound 2. The contents of the marker 
compounds were found to be 3.1% for compound 1, 3.4% for compound 2, 3.4 % for 
compound 4, and 26.8 % for compound 5 & 6. Antibacterial and wound healing 
potential of the standardized F5 fraction of D. linearis was subsequently investigated 
using several in vitro assays. From the time killing assay, minimum inhibitory 
concentration (MIC) assay and scanning electron microscopic images, F5 was found 
to exert bacteriostatic effect against S. aureus and P. aeruginosa. Moreover, F5 was 
also able to potentiate the antibacterial effect of few conventional antibiotics, 
namely, chloramphenicol, penicillin G and ampicillin against S. aureus and MRSA. 
On the other hand, F5 was able to enhance the proliferation of fibroblast cells and 
induce cell migration in the scratch-wound assay. In addition, it protected the cells 
against hydrogen peroxide induced oxidative stress and was non-cytotoxic towards 
both human and mouse fibroblast cell lines up to the tested concentrations of 
500µg/mL. Taken together, the present study provided novel information to support 
the traditional use of this plant for skin infections. In vivo studies are warranted to 
further explore the potential of D. linearis as a wound healing agent. 
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 CHAPTER 1  
BACKGROUND  
 
Chronic wounds are a growing threat which affect a large portion of 
population and signify a considerable public healthcare burden worldwide. In 
developed countries such as United States and UK, the healthcare cost to treat non 
healing wound is estimated to be about 2.5-25 billion annually (Posnett & Franks, 
2008;Sen et al., 2009). With the increasing incidences of post-surgical wound, 
diabetes and obesity worldwide, the burden of chronic wounds is expected to be on a 
rise. Wound healing is rarely seen as a problem in healthy individuals. Under normal 
circumstances, a wound usually follows through the reparative process in a timely 
and orderly manner. However, under certain physio-pathological conditions such as 
stress, obesity, diabetes, local infection, hypoxia, aging, malnutrition and 
immunodeficiency, the wound healing process may be impaired (Harding, 2008). 
One of the critical factors that delay the wound healing process is bacterial 
infection. When the skin, which acts as the major epithelial barrier between the body 
and the hostile atmosphere, is wounded, it becomes vulnerable for microbial 
invasion. Among some of the common bacteria which cause wound infections are the 
Gram negative P. aeruginosa and Gram positive S. aureus (Guggenheim et al., 
2009). Both P. aeruginosa and S. aureus are opportunistic bacteria that are found in 
soft tissues of the body and known to be harmless pathogens. However, in 
immunocompromised individuals such as AIDS patients and those suffering from 
chronic illnesses, infections caused by these bacteria may lead to serious problems. 
In the past, bacterial infection can be easily treated with antibiotics. However, with 
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the non-systemic and indiscriminate use of antibiotics over time, bacteria strains that 
are resistant towards these antibiotics began to develop leaving the conventional 
antibiotic ineffective. At present approximately 90–95% penicillin resistant S. aureus 
and 70–80% of methicillin resistant S. aureus strains have been reported around the 
world (Chambers, 2001; Casal et al., 2005). Hence, there is an urgent need for newer 
and more effective antibiotic agents. While the development of new antibacterial 
agent is costly and time consuming, an alternative strategy to address such problem 
is to use combination of drugs. Several studies have reported the synergistic effects 
of plant extract or natural product when it is used together with conventional 
antibiotics. For instance pomegranate extract, myricetin and pyridine alkaloid which 
were isolated from Jatropha elliptica, exhibited potent synergetic effect when they 
are employed together with conventional antibiotics such as chloramphenicol, 
gentamicin, ampicillin, tetracycline, and oxacillin (Braga et al., 2005; Lin et al., 
2005). While conventional antibiotics are mostly of microbial origin, development of 
resistance towards these antibiotics are relatively easy due to random mutation 
compared to plant secondary metabolites which have vast and unique structures that 
are not of common to microbes (Cowan, 1999). Hence, recent studies have been 
focusing on combining conventional antibiotics with plant extract/compound in order 
to reduce the chances of developing antibiotics resistant bacterial strains (Ghaleb et 
al., 2010). This will not only prolong the effective lifespan of an antibiotic, it can 
also reduce the side effects caused by these antibiotics.  
Dicranopteris linearis (local name: resam) is a fern used traditionally in 
Southeast Asia to control fever and to treat external wounds, ulcers, boils and 
intestinal worm infection  (Piggott, 1988; Chin, 1992). Studies have shown that it 
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exhibits strong antioxidant effects and have antibacterial properties towards B. 
cereus, M. luteus, S. aureus, P. aeruginosa and E. coli (Lai et al., 2009). However, 
these few studies are insufficient to provide support for an evidence-based use of the 
plant for wound infection. As such the present work was carried out with the 
following specific objectives: 
 
1. To prepare a fraction of D. linearis that with bioactive constituents 
2. To carry out isolation, characterization and structure elucidation of 
major compounds found in the bioactive extract of D. linearis 
3. To develop and validate a HPLC-DAD analytical method for 
standardization of the bioactive fraction of D. linearis 
4. To evaluate the antibacterial properties and synergistic effect of the 
standardized fraction with conventional antibiotics 
5. To evaluate the wound healing potential of the standardized fraction 
of D. linearis through in vitro models.  
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Figure 1.1: Research flowchart 
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 CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Types of wound 
In general, wound is referred to an injury of the skin, while infected wound is 
a condition in which microorganisms have colonized the wound causing either a 
delay in healing or deterioration of the wound. Infectious wounds vary in severity 
from benign to life threatening, mainly based on the virulence of the pathogen 
involved, the pathology of the affected area and the primary health condition of the 
patient (Fadeyibi et al., 2013). Skin damage can be classified into two major types, 
which is acute or chronic wound. External damage to intact skin such as surgical 
wounds, bites, burns, minor cut, abrasion and lacerations are classified as acute 
wounds (Bowler et al., 2001). Usually these types of wounds are expected to heal 
within a predictable time frame during which a series of healing processes occur 
naturally. Conversely, chronic wounds such as leg ulcers, foot ulcers, abscesses and 
pressure sores are most frequently caused by predisposed pathophysiological 
abnormalities of the patient. Health conditions such as diabetes mellitus which 
impair the tissue perfusion and other factors such as aging, obesity, smoking, poor 
nutrition, and immunosuppressive associated diseases may also aggravate the 
development of chronic wound resulting in slow and unpredictable healing 
(MacGregor, 2008). Although acute and chronic wounds differ in terms of their 
severity and pathological conditions, microbial infection remains as a common 
clinical problem to both types of wounds.  
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2.2 Bacterial activity in wound 
Wound infection delays the healing process, which can eventually lead to 
other complications. Various bacteria causes wound infection and among them are 
the aerobic or facultative pathogens such as S. aureus, P. aeruginosa, and β-
hemolytic Streptococci (Gadepalli et al., 2006). The emergence of antibiotic resistant 
virulent pathogens and poor disease management has practically led to a steady 
increase of infectious skin diseases. A study conducted by European Centre for 
Disease Prevention and Control (2009) estimated 380,000 healthcare associated 
infections annually in Europe Member States hospitals are due to antibiotic-resistant 
bacteria, including those of the respiratory tract, skin or soft tissues and urinary tract. 
Chambers and colleagues (2001) also reported that in most of the Asian countries, 
around 70-95% of S. aureus strains were found to be resistant to penicillin and 
methicillin. Besides, up to 75% of morbidity following injuries is also found to be 
related to infections (Church et al., 2006), usually caused by methicillin-resistant S. 
aureus (MRSA) and P. aeruginosa (Vindenes & Bjerknes, 1995). 
Staphylococci are non-motile, Gram-positive cocci that causes postoperative 
wound infection (Martone et al., 1992). In a healthy individual, more than 10
6 
virulent staphylococci are needed to cause a minor infection, however in an 
immunocompromised person 10
2
 is sufficient enough to initiate an infection. In 
addition, the number of organisms which are needed to initiate infection can also be 
reduced due to the placement of foreign medical devices such as central nervous 
catheters, hemodialysis catheters, tracheostomy tubes, intravascular catheters, 
artificial heart valves, sutures, and prosthetic joint devices (El-Ahdab et al., 2005). 
During a staphylococcal infection, asymptomatic carriers might persist to function as 
reservoirs for the organism probably due to formation of biofilm. Biofilms are 
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formed by adherent bacteria cells that can attach to living or non-living matrixes 
through a self-produced matrix of extracellular polymeric substance (EPS). Hence, 
the carrier state of staphylococcal infection cannot be easily eliminated by β-lactam 
antibiotics or vancomycin treatment. Various topical and systemic agents including 
rifampin, ciprofloxacin, minocycline, trimethoprim-sulfametoxazole, mupirocin, and 
novobiocin, have been used alone and also in combination for treatment of 
staphylococcus infections and the results are variable. Most of the time, the failure in 
treatment for such infections are due to the un-systemic use of antibiotic resulting in 
the emergence of resistant strains (Mulligan et al.,1993). 
The rod shaped gram negative bacteria P. aeruginosa has been reported to be 
the second most frequent agent to cause skin infections (Hillier et al., 2008). Though 
in a healthy individual, P. aeruginosa rarely provokes infection, it poses serious 
health risk to immunocompromised patients. P. aeruginosa accounts for about 10% 
of infections among the in-hospital patients (Schimpff et al., 1970; Germiller et al., 
2005). The ubiquitous nature of P. aeruginosa has made it very versatile, hence 
largely contributing to its ecological success as opportunistic pathogen. It can grow 
at a broad range of temperature (37-42
◦
C) and it is also fairly resistant to 
disinfectants. 
 
2.3 Antioxidant activity in wound healing 
Antioxidants are molecules that can protect cells from oxidative damage by 
scavenging free radicals. At the wound site, as part of human`s innate immune 
system, there is tendency for a sharp rise in the concentration of reactive oxygen 
species (ROS) due to the stimulation of various inflammatory cells such as 
neutrophils, lymphocytes, macrophages and platelets (Waldorf & Fewkes, 1995). 
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Although small amount of these ROS are important to trigger off a cascade of 
healing events, excessive amount of these free radical are injurious to the 
surrounding tissues and can cause serious damage to it. To counter oxidative 
damage, body utilizes endogenous antioxidant enzymes such as superoxide 
dismutases, catalases, glutathione peroxidases and peroxiredoxins, secreted by the 
adjoining cells (Ghosh & Gaba, 2013).These compounds are reported to enhance cell 
proliferation and exhibit antibacterial effects. These properties are useful for the 
rapid healing while protecting the wounded site from deleterious effect of infection 
(García-Pérez et al., 2014).  
 
2.4 Process of wound healing 
The progression of wound healing can generally be divided into several 
stages such as coagulation, inflammation, cell proliferation and migration, re-
epithelialization and subsequently tissue remodeling (Fitzmaurice et al., 2010), 
Figure 2.1. These phases of wound healing process are distinct yet overlapping. For 
an example, while events in inflammation phase are actively occurring, tissue 
formation process also begins. A unique group of cytokines regulate and synchronize 
wound healing. They are known as growth factors that are secreted from 
macrophages, neutrophils, endothelial cells, lymphocytes, fibroblasts and 
thrombocytes. Many of these cytokines play the role in wound healing processes, 
such as fibroblast-derived growth factor (FGF), tumour necrosis factor (TNF), 
platelet-derived growth factor (PDGF), granulocyte-macrophage colony stimulating 
factor (GM-CSF), epidermal growth factor (EGF), transforming growth factors 
(TGF) α and β, as well as insulin-like growth factor (IGF). When an open wound is 
generated, platelet plug and blood clot are formed to temporary seal the wound in a 
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process termed as coagulation. Platelet plug activates macrophages and other cells in 
the wound area to produce various chemokines, growth factors and cytokines, 
causing influx and activation of larger number of macrophages. The adaptive 
immune system response is then stimulated (Waldorf & Fewkes, 1995). 
Inflammatory phase which usually lasts for about 4 – 6 days in normal course of 
wound repair is then initiated where a number of antibodies, immune cells, enzymes 
and growth factors are recruited to the wound area. Reactive oxygen species (ROS) 
are also released in large amount to protect the wound against invading 
microorganism (Schafer & Werner, 2008). Taking cue from the inflammation phase, 
the most prominent event of wound healing process, the cell proliferation and 
migration phase are initiated. During proliferation phase, the fibroblast cells 
replicates and angiogenesis of new capillaries also occurs to support the development 
of granulation tissue (Ito et al., 2007). The newly formed capillaries branch out and 
invade fibrin matrix at the wound site, whereby it forms a branched and complex 
vascular network. Proliferation of certain cell lines such as epithelial cells, 
fibroblasts, and endothelial cells was reported to be induced by various growth 
factors (Kim et al., 1998). After the proliferation phase, epithelialization process then 
takes place where epithelial cells resurface and fills up the wound gap. The migration 
of epidermal cells can usually be seen from the margins of the wound to the wound 
matrix (Kanzler et al., 1986). Finally, the wound healing progresses into the 
remodeling phase, during which the wound strength increases as the fibroblasts 
organize and cross-link the collagen. The wound then contracts and the capillary and 
fibroblast density regress and decrease (Hsu & Mustoe, 2010). 
Since wound healing is a highly organized process, an active wound healing 
agent should contribute in one or more phases of the healing process, in a proper 
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sequence and at the right time frame to show improved efficacy. Preferably a plant-
based remedy should promote at least two different processes before it can be said to 
have some scientific support of its traditional use for wound healing (Houghton et al., 
2005). It should exhibit three main effects; antioxidant, antimicrobial and cell 
proliferation activity in order to contribute positively to the wound healing process 
(Ghosh & Gaba, 2013). 
 
 
 Figure 2.1: Phases of cutaneous wound healing (Patrick et al., 2013) 
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2.5 Plant based medicine for wound healing 
Herbal medicines have been used since the ancient civilisation for the healing 
of wounds. Even today with the advancement attained in modern medicine, many 
people are still relying on herbal medicines as an alternative therapy to heal wound 
due to the cost effectiveness, accessibility and lesser side effects of herbal 
preparations. During the last two decades, there have been increased interests to 
utilize plant preparations in wound healing and to understand the active constituents 
that promote and modulate the healing process. There are numerous scientific reports 
on plant such as aloe vera, turmeric, lavender and tea tree that are used traditionally 
to accelerate wound healing. In many cases the scientific findings were found to 
substantiate the traditional use of the respective medicinal plants (Krishnan, 2006). 
Selection of plants for these scientific studies are often guided by traditional 
practices such as Ayruvedic medicine, Traditional Chinese Medicine (TCM) and folk 
medicine (Kumara et al., 2007; Rawat et al., 2012;Wang et al., 2013). For instance, 
turmeric, the yellow powder used as spice, is usually applied as paste at the wounded 
area and the juice is taken orally to reduce inflammation (Aggarwal & Prasad, 2011). 
These traditional uses prompted systematic scientific research to learn more about 
the active constituents, the pharmacological properties and the absorption nature of 
this herb.  Studies were carried out at pre-clinical and clinical stages and turmeric 
was found to be a promising candidate to be developed into a wound healing agent 
(Krausz et al., 2015). This is a typical example on how traditional practices of using 
plants provide pharmacological basis for their development into wound healing 
therapeutics. 
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2.6 Ferns with wound healing and antibacterial properties  
Malaysia is one of the countries where Pteridophytes are found in abundance. 
Ferns belong to Pteridophyta, are known for its medicinal values and it had been 
widely used in the traditional medicinal system. Two species from the genus 
Davallia, Davallia mariesii and Davallia solida have been used as painkiller, anti-
inflammatory agents and also for healing of fractured bones (Chang et al. 2007; 
Whistler, 1992). Dynaria fortunei and Microsorum scolopendria belongs to the same 
family have been used for skin inflammation, lumbago treatment and wound healing 
(Lee et al., 2008; Bloomfield, 2002). Acrostichum aureum is used to treat wound and 
ulcer (Morrison et al.,1994) while Blechnum orientale  are being  used as tonic and to 
cure wound cicatrization (Defilipps et al., 1998). The rhizome extract of Drynaria 
quercifolia was found to inhibit the growth of at least 6 bacteria strains significantly 
(Kandhasamy, 2008). Phytochemical studies revealed that Pteridophytes are rich in 
triterpenoids, sesquiterpenes, catechins, flavonoids, steroids and glycosides which 
are important source of therapeutic drugs (Anuja et al., 2010; Liu et al., 1999; 
Economides & Adam, 1998). Most of the reported phytochemicals are known for 
their radical scavenging activity.  
 
2.7 Commercial products of fern with wound healing properties 
 One of the products developed from a medicinal fern used traditionally in 
South America to treat dermatitis is “Anapsos”. The product is registered under 
Spanish Health Department and it contains the standardized extract of a fern, 
Polypodium leucotomas as the active ingredient. The product is widely used to treat 
dermatological disorders such as psoriasis and atopic dermatitis and it is also found 
to be effective as photoprotectant, immunomodulator and antioxidant (Caccialanzaet 
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al., 2007).P. leucotomas, has also been used to develop another skin product called 
“Fernblock” which is used as an anti-aging and sun-block cream. Several major 
compounds such as 3,4-dihydroxybenzoic acid, 4-hydroxybenzoic acid, vanillin acid, 
caffeic acid, 4-hydroxy cinnamic acid, ferulic acid and five chlorogenic acid isomers 
had been identified from the P. leucotomas extract and they are used to standardize 
the product (Carcia et al., 2006).The success of these products indicates the potential 
use of some ferns to be developed into pharmaceutical products to treat skin 
infections. 
 In spite of the traditional uses of a number of ferns for treating skin related 
ailments, the potential use of them as novel source of drugs for the treatment of skin 
diseases is still poorly explored. Only a small number of these plants have been 
investigated phytochemically and to a lesser extend studied systematically for their 
pharmacological properties. One such fern that had been used traditionally to treat 
skin diseases, but has rarely been investigated for its pharmacological action is D. 
linearis (Burm.) Underwood. 
 
2.8 Dicranopteris linearis (Burm.) Underwood 
2.8.1 Taxonomy and distribution 
Dicranopteris linearis (Burm.) Underwood (synonym: Dicranopteris 
dichotoma,(Iwatsuki et al., 1993) also known as “resam” is a creeping fern 
indigenous to Malaysia. It belongs to the Gleicheniaceae family and subfamily of 
Gleichenioideae. This plant grows horizontally at ground level with a typical two 
main dichotomous forking stem which also branch further to about 3–4 times. 
Usually, the sporangia, where spores are produced and stored, are found under the 
mature fronds of D. linearis. The rhizome is several meters long and grows up to 
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5mm in diameter. The plants rapidly grow into thickets up to two meters tall. An 
illustration of D. linearis (Burm.) Underwood is given in Fig 2.2. 
D. linearis is widely distributed in the subtropical and tropical regions 
including Southeast Asia, Polynesia, Central Africa, Madagascar and Northern & 
Southern America (Zhao et al., 2012), Figure 2.3. There are four common 
Dicranopteris species, namely, D . linearis, D. pectinata, D. flexuosa and D. curranii 
which are found in humid subtropical and tropical regions of the world. Among them 
D. curranii and D. linearis are found to be predominant in Malaysia (Negishi et al., 
2006). Dicranopteris species are well adapted to highly-lit area; it grows and 
expands fast under this condition (Kochummen, 1977; Russell et al., 1998). 
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Figure 2.2: Dicranopteris linearis (Burm.) Underwood. 
Source, Hooker & Greville, 1831 
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Figure 2.3: Geographical distribution of D. linearis, the yellow squares indicate the 
presence of D. linearis 
(Source: http://www.discoverlife.org/mp/20q?search=Dicranopteris+linearis) 
 
2.8.2 Ethnopharmacological relevance of D. linearis 
Traditionally the leaves of D. linearis are crushed and made into poultice, to 
treat fever, as wound dressing and as an anthelminthic (Upreti et al., 2009). The 
decoction is drunk in Thailand against insomnia and to wash children with skin rash 
while in Hawaii it is used for constipation (Chin, 1998). In Malaysia, D. linearis is 
used to treat some of the chronic wounds like, ulcers, abscesses, boils, sores and 
gastritis (Piggott, 1988; Chin, 1998).  
 
2.8.3 Research background of D. linearis 
Several studies showed that the crude extracts of D. linearis possess 
antioxidant (Lai et al., 2009), antibacterial (Liu et al., 1999), anticancer (Rodzi et al., 
2013) anti-inflammatory (Zakaria et al., 2011) and gastro-protective effect (Hussaini 
et al., 2012). The methanol and chloroform crude extracts of D. linearis was reported 
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to exhibit hepatoprotective effect which could be due to the presence of antioxidant 
compounds such as rutin and quercetin (Mamat et al., 2013; Ismail et al., 2014; 
Kamisan et al., 2014). In addition, the water and chloroform extract of D. linearis 
was found to possess antinociceptive and antipyretic activities (Zakaria et al., 2006; 
Zakaria et al., 2008).  
 
2.8.4 Phytochemical constituents of D. linearis 
The phytochemicals of D. linearis have not been extensively explored. Only a 
handful of publications can be found regarding the identification of natural products 
from this species. Two main classes of compounds which have been reported from 
D. linearis are the polyphenols and terpenoids. Among the polyphenol compounds 
reported, the two highly oxygenated phenolic compounds with a spiral dilactone 
structure, dichotomain A (1) and dichotomain B (2) are found to be exclusive to D. 
linearis (Li, et al., 2006). Hence they are taxonomically significant to this species. 
Astragalin (3), quercetin (4) and rutin (5) are some of the common flavonoids 
isolated from D. linearis. Li et al., 2007 isolated few tetranorclerodanes and 
clerodane-type diterpene glycosides from the acetone extract of D. dichotoma, which 
is the synonym of D. linearis. Two clerodane-type diterpene glycosides, namely (6-
O-acetyl-β-D-glucopyranosyl-(1→4)-R-α-rhamnopyranosyl) cleroda-3,14-dien-13-ol 
(6) and (4-O-acetyl-β-D-glucopyranosyl-(1→4)-R-α-rhamnopyranosyl) cleroda-3,14-
dien-13-ol (7), 18-hydroxyaylthonic acid (8), 18-oxo-aylthonic acid (9), aylthonic 
acid (10) and cleroda-3, 14-diene-6, 13-diol (11) are some of the compounds that 
were isolated and identified by Li and his colleagues (2007). The same research 
group also isolated and reported few other terpenoids from D. linearis, clerodane-
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type diterpene glycoside (12), 15-hydroxylabd-8(17)-en-19-oic acid (13) and 
junicedric acid (14) (Li, et al., 2008).  
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Figure 2.4: Chemical structures of compounds isolated from D. linearis
 
2.9 Isolated compounds versus herbal drugs 
Plant-derived products have dominated the human pharmacopoeia for 
thousands of years and remained as an endless source of medicine. The discovery of 
H
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    (9)       (10) 
  (11)       (12) 
   (13)       (14) 
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aspirin, a synthetic drug derived from a natural product salicylic acid in 1897 
however had shifted the herbal medicine paradigm to mono-drug therapeutics. 
Mono-drug therapeutic concept involves the use of a single plant derived or synthetic 
drug to treat complex diseases. The concept of identifying a single chemical 
compound responsible for the therapeutic effect of a plant has thus been the 
paradigm shift in drug discovery in natural product (Williamson, 2001). With the 
advent of structure activity-guided organic synthesis and high throughput screening 
(HTS), this approach is easier to realize compared to using the conventional 
screening approach. The use of single compound provides the ease of studying the 
pharmacokinetics and pharmacodynamic properties, the mechanism of actions, and 
the side effects (Mohammad et al., 2005). There are numerous examples of drugs 
originated from natural products. Quinine, penicillin and pilocarpine are some of the 
earliest drugs derived primarily from natural sources (Daniel et al., 2012). Morphine 
and digoxin are also examples of well-established drugs. Morphine was isolated from 
opium produced from the poppy plant (Papaver somniferum) while digoxin is a heart 
stimulant originated from the flower of Digitalis lanata (Ramesh & Sudhir, 2015).  
Some newer drugs such as artemisinin (antimalarial), paclitaxel and irinotecan 
(anticancer) are also derivatives of natural products (Harvey, 2008; Katiyar, et al., 
2012). 
Contradictory to the mono-therapeutic approach is the use of plant extracts or 
herbal preparations which consist of a mixture of varied compounds. These 
preparations may be obtained from a single plant or a mixture of various plants. The 
use of herbal preparations has formed the basis of treatment in most traditional 
medicine systems. The aim of using multicomponent herbal preparations is to 
attenuate certain medical properties, reduce toxicity and to improve bioavailability of 
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the pharmacologically active principles (Schmidt et al., 2008). Most frequently, the 
therapeutic effect of plants are due to the combinational effect of several compounds 
and in many cases the potency of the whole plant declines as it is purified into 
fractions or single compounds (Cravotto et al., 2010). Repeated fractionation and 
isolation process have a bottleneck effect to the complex plant extract, leading to the 
loss or reduction of the suboptimal active compounds which may have other 
pharmacological properties (Raskin & Ripoll, 2004). It is interesting to note that, 
with the rising occurrence of resistance and variable response to treatments, 
researchers are reverting to the “synergistic” approach, where combinations of 
different drugs with different targets are recruited. As the plant extract contains pool 
of compounds and it is cheaper to produce, this approach has a greater advantage 
over the use of single drugs. Enhanced bioavailability, synergy, and the additive 
properties of the constituents are the obvious advantages of the herbal medicine. 
 
2.10 Standardized plant extract for pharmacological studies 
In many parts of the world, plant derived medication still forms an integral 
part of healthcare and are being used to treat myriad of diseases. However many 
herbal preparations do not have a defined dosage, information on their chemical 
compositions and possible adverse reactions. Further to this is the poor quality 
control of these herbal preparations resulting in inconsistent and variable 
pharmacological effects (Canuto et al., 2012). Therefore, standardization of the plant 
extracts and herbal preparation have become an important measure for application in 
clinical and pharmacological practice (Eng, 2004). Standardization of plant extracts 
requires complete quality control at all stages, from the raw material to finished 
product (Carmona & Pereira, 2013). It involves the collection of comprehensive data 
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about the source of plant material and the fingerprint of the extract with at least four 
marker compounds (Garg et al., 2012). The information about the plant material such 
as appearance, maturity, drying and storage conditions can be collected through 
careful observation on the growing and extraction techniques while the fingerprint of 
the extract can be obtained through various analytical techniques such as TLC, 
HPTLC, HPLC and GC. Standardization is important to ensure the reproducibility 
and effectiveness of the herbal preparations extract while ensuring the chemical 
consistency, reproducibility of the pharmacological effect and the therapeutic 
efficiency (Bauer, 1998).  
 
2.11 Separation techniques 
In order to standardize the plant extract or fraction, identification of the 
bioactive or marker compounds is crucial. Various separation techniques can be used 
to separate and isolate the constituents according to its chemical nature. In most 
separation methods, the principle separation takes place through the selective 
distribution of the compounds between the mobile phase and the stationary phase. 
 Thin layer chromatography (TLC) is one of the most frequently used, cost 
effective, quick separation methods that have employed since many decades ago 
(Irena et al., 2009). The adsorbents such as silica or reverse phase silica (e.g.: C18, 
C8, C4, C-cyclohexyl, C-phenyl and C-cyano) coated on aluminum or glass plates are 
used for TLC. TLC plates are usually supplied in 20cm × 20cm size and it can be cut 
into various sizes according to the user‟s preference. The mixture of natural products 
is spotted at the origin of the TLC plate and developed in a glass jar with saturated 
atmosphere of the developing solvent. The solvent is varied by mixing two or more 
solvents with different polarity. The separation of the mixture at the sample origin 
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occurs according to the polarity of the mobile phase of as it moves up on the TLC 
plate due to capillary action. The basic information of the chemical nature of the 
compounds is obtained by viewing the TLC plate under ultraviolet (UV) illumination 
or by spraying with appropriate reagent. TLC is a preliminary step to identify the 
optimal solvent combinations for further identification and purification of the 
mixture (Gilbert & Martin, 1998).  
Once the optimal separation has been attained on TLC, the same developing 
solvent system can be applied on preparative thin layer chromatography (Prep-TLC). 
Prep-TLC is a scale up procedure of TLC which is used to separate and isolate the 
mixture at a larger scale. However, most frequently this technique is used as a final 
step of purification when the mixture contains less than five compounds in order to 
isolate the pure compounds. The separated compounds are detected by non-
destructive UV method or by reacting with a reagent. The particular separated bands 
are then scraped out from the plate and desorbed using an appropriate solvent that is 
able to elute the compound.  
Another inevitable separation method in natural products research is column 
chromatography. Two classical types of column chromatography are the open 
column and flash column. Open column uses the gravitational force to elute out 
separated compounds, while flash column chromatography uses external air forces 
such as nitrogen pressure, vacuum suction or control pump for compound elution. 
Though open column is more cost effective, recently it has largely been replaced by 
flash column chromatography methods due to shorter eluting time, efficiency and 
better separation. In column chromatography the selection of appropriate mobile 
phase composition, diameter and length of the column, as well as the sample loading 
size are essential to purify individual chemical compounds from a mixture of 
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compounds. The selection of these chromatography parameters depends upon the 
complexity of the sample mixture and the types of interactions between the mixture 
and the stationary phase (Ren et al., 2013). 
Dry column vacuum chromatography (DCVC) is an alternative to flash column 
chromatography. Generally it uses less solvent and reduces the required amount of 
silica compared to a wet column. Unlike flash column chromatography where the 
sorbent bed is always maintained wet, DCVC uses a fractionation procedure in which 
after each step of gradient elution the column will be dried out before the addition of 
the next solvent system. This method is usually used for separating highly complex 
crude mixture into smaller fractions (Pedersen & Rosenbohm, 2001). In addition to 
these classical chromatographic techniques, there are also other more sophisticated, 
high-end separation technologies nowadays, such as high performance liquid 
chromatography (HPLC), counter current chromatography and supercritical fluid 
chromatography which provides more specificity and defined control over compound 
separation through their automated systems. By combining various chromatographic 
techniques at various stages of the purification process, reasonably pure compounds 
can finally be obtained from the crude extracts. 
 
2.12 Compound characterization and structure elucidation 
There are several spectroscopy and spectrometry techniques available to 
elucidate the structure of the isolated compounds. Spectroscopy is the means of 
understanding the interaction between matter and radiated energy while spectrometry 
is the method used to obtain a quantitative measurement of the spectrum. 
Ultraviolet-visible (UV-Vis) spectroscopy is based on the electronic 
transition of the chemical compounds which absorb light in the UV-Vis region. 
